Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.

Pharmacogenomics - 1 Sept 2007

Hartford Christine M, Dolan M Eileen

Abstract excerpt

Patients treated with anticancer chemotherapy exhibit variation, both in terms of tumor response and the incidence and severity of adverse effects. The etiology of this variation is multifactorial with genetic factors likely contributing to a significant extent. Pharmacogenetic and genomic studies can be used to identify the genetic variants that contribute to interindividual variation in susceptibility to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cell Survival
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 17924831
DOI: 10.2217/14622416.8.9.1159
PMCID: PMC2665166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.PMID 17924831Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Genetic variants contributing to daunorubicin-induced cytotoxicity.Semantic proximity Read ↗

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.Semantic proximity Read ↗

Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans.Semantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs.Semantic proximity Read ↗

Cancer pharmacogenetics.Semantic proximity Read ↗

Pharmacogenomic Characterization of US FDA-approved Cytotoxic DrugsSemantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

From Genes to Personalized Cancer Care: A Systematic Review of Toxicity-Associated Genetic Variants in Solid Tumor TreatmentsSemantic proximity Read ↗

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.Semantic proximity Read ↗

The use of genomic information to optimize cancer chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.